Zhejiang Medicine Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is DAPTOMYCIN, with a corresponding US DMF Number 26778.
Remarkably, this DMF maintains an Active status since its submission on January 07, 2013, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 11, 2013, and payment made on January 09, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II